Uncategorized
Portal’s Houston portfolio company CrossBridge Bio acquired by Eli Lilly!
Portal’s Houston-based portfolio company focused on ADCs, CrossBridge Bio, was acquired by Eli Lilly in a deal worth up to $300 million! Congratulations to the CrossBridge Bio team!
Get in touch
Chicago | Providence | New Brunswick | Houston | Dublin
©2026 Portal Innovations, LLC
Sign up for our monthly newsletter
Stay up-to-date on the latest VC, biotech, and med tech news in Chicago and across the U.S. Sign up with your email address below to get our monthly newsletter delivered to your inbox!